CVM si ecsdaaiots htiw cfiitgenn ngaor lntartasnp tnpisa.te MCV is anttemdsirt iva lsexau not,catc ngrao trpnl,tasna ro lyctvaleir via aeanplct. atiRitoneacv of MCV rccsou ni het nu.smupsisomeperd
rnaOg tptsarnnla asnpetti aer at an secrieadn srik fo CMV e.niopmuna
eh swa eervn eignv igccaonilrv - i sdue htta sa a eulc evor narttsnpla ceonerijt
yhW wludo htsi not eb atcue nartanlpst recnojiet eadlgin to D?ASR Teh ieaeirntnc si a,eetledv dna I ees nya nroaes ywh ti uoldw be edveealt oynbde ejcortnei
via @sammyj98 via UpToDate:
Universal prophylaxis with valganciclovir
or ganciclovir
is typically given to patients at risk for cytomegalovirus (CMV) reactivation (eg, seropositive recipients and those with seropositive donors). The duration of therapy often depends on the type of organ transplanted, the risk status of the patient, and individual institutional practice. Some transplant centers prefer to use a pre-emptive approach (eg, routine CMV viral load monitoring within initiation of treatment when reactivation becomes evident) for specific patient populations.
submitted by ∗amorah(115)
It can be re-accessed by making a purchase.
Purchase your membership here
$279$49 65% OFFeevrF tg&-; rlue uto flte catnruervil eailruf MP-XM ST oriylhxspap t&;-g rule otu nPyctsmuoies dKoijirieyev nc latrstpann ubt no WRCB/BC in eiurn g-t;& eulr out lnttasprna etrojncie
viLegan VMC nda altaiypc ryticuabecmmo as the eingmnira wot sip.noto VCM is mroe elylki ni a rtnalntpas eati.pnt
$279$49 65% OFF